A Study of JZP150 in Adults With Posttraumatic Stress Disorder
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter
study of the safety and efficacy of JZP150 in the treatment of adult participants with
post-traumatic stress disorder (PTSD).